Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis

Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis

Introduction: The CFTR modulator drug elexacaftor/tezacaftor/ivacaftor (ETI) was shown to improve CFTR function and clinical symptoms in patients with cystic fibrosis (CF) with at least one F508del allele. Recently, some case reports suggested potential side effects of ETI on mental health with an i...

Full description

Bibliographic Details
Main Authors: Linus Piehler, Ralf Thalemann, Christine Lehmann, Stephanie Thee, Jobst Röhmel, Zulfiya Syunyaeva, Mirjam Stahl, Marcus A. Mall, Simon Y. Graeber
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Pharmacology
Subjects:
cystic fibrosis
elexacaftor/tezacaftor/ivacaftor
mental health
depression
anxiety
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1179208/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1179208/full

Similar Items